Recurrence of Arrhythmias After Pulmonary Veins Isolation Detected by ICM
NCT ID: NCT00789139
Last Updated: 2015-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
47 participants
INTERVENTIONAL
2008-10-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Describe how the MD is using the information of the ICM in addition of standard FU(clinical exam and holter 24h)post AF ablation(1 year FU).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation
NCT05781282
Investigation of Substrates Associated With the Recurrence of Atrial Fibrillation After PV Cryoablation
NCT03587181
"UNMASKING Study" For Atrial Fibrillation Recurrences Typing in Early Postoperative Period
NCT01164319
Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial Fibrillation
NCT01645917
Investigation of Therapeutic Ablation Versus Cardioversion for AF
NCT03907982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AF monitoring by ICM
Only one arm
ICM Implantation
Sub cutaneous implantation of the ICM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICM Implantation
Sub cutaneous implantation of the ICM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed Consent signed,
* Age between 18 \& 75
Exclusion Criteria
* Non compliant patient
* Pregnant women
* Left Atrial thrombus
* Endocarditis, infection
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr Ange FERRACCI
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Ange FERRACCI
CARDIOLOGIST
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ANGE FERRACCI, md
Role: PRINCIPAL_INVESTIGATOR
Unity Health Toronto
ANDRE PISAPIA, MD
Role: STUDY_DIRECTOR
Unity Health Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Joseph Hospital
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAPIDXT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.